Partner with Javara to accelerate your GLP-1 trials

I’m Interested

Through our unique model of embedding staff and infrastructure into large healthcare organizations, we enable access to studies at the point of care — for both patients and physicians.

Our extensive outreach and engagement efforts have generated an enriched pool of 1,600+ patients (and growing) across eight US geographies. Each of these patients has been pre-screened for GLP-1 trials with a confirmed interest in proceeding to formal screening for any new trials.

Ready to supercharge your GLP-1 study enrollment?
Contact Javara today!

Download Javara’s Accelerated Start-up Case Study

Read how our site staff and centralized support teams delivered real, meaningful results for the study sponsor in a recent GLP-1 clinical trial.

Download Now

Javara has proven experience, with our sites being first to enroll patients on a recent GLP-1 global trial.

We have a 90% patient retention rate due to our personalized approach and connecting with patients through their trusted physicians.

Our investigators and staff have been thoroughly trained on the distinctive needs of this unique patient population.